This is not a one-size-fits-all protocol
After spending $100 million on the drugs for weight loss in 2024 and seeing sizable operating losses to boot, Point32Health announced in May that it would stop automatically covering the drugs for obesity starting in 2026
While they have not issued any specific warnings about NAION or other vision loss risks beyond those related to diabetic retinopathy, ongoing safety evaluations are in progress
With a combination of metformin 2000 mg/d, liraglutide 0.6 mg/d subcutaneously increased to 1.8 mg/d over 2 months, levonorgestrel-ethinyl estradiol (no dosage listed), dapsone 100 mg/d, and finasteride 5 mg/d, there was a marked reduction in nodules and abscesses after 6 months, with a weight loss of 40 lb (19% body weight)
NORTH AMERICA GLUTATHIONE MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION) TABLE 242
It doesnt cleanse the body in the way wellness marketing often implies